Trade

Lotus Eye Hospital and Institute share price

High risk
  • 52%Low risk
  • 52%Moderate risk
  • 52%Balanced risk
  • 52%High risk
  • 52%Extreme risk
  • 129.90(4.97%)
    February 18, 2026 10:12:51 AM IST
    • NSE
    • BSE
  • Vol : 40.44 K (NSE + BSE)
    Last 20 day avg : 41.73 K

Lotus Eye Hospital and Institute is trading 4.97% upper at Rs 129.90 as compared to its last closing price. Lotus Eye Hospital and Institute has been trading in the price range of 129.90 & 121.00. Lotus Eye Hospital and Institute has given 3.99% in this year & 3.20% in the last 5 days. Lotus Eye Hospital and Institute has TTM P/E ratio 343.01 as compared to the sector P/E of 29.67.The company posted a net profit of 0.12 Crores in its last quarter.Listed peers of Lotus Eye Hospital and Institute include Apollo Hospitals Enterprise (0.73%), Fortis Healthcare (0.15%), Max Healthcare Institute (0.44%).The Mutual Fund holding in Lotus Eye Hospital and Institute was at -% in . The MF holding has - from the last quarter. The FII holding in Lotus Eye Hospital and Institute was at 0.01% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Feb 18, 2026, 05:58 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.89
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.06
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    4.12
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    343.71
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -9.31
    Indicates undervaluation
Price range
Day Range
Lowest
121.00
Highest
129.90
52 week range
Lowest
55.31
Highest
147.60
Lotus Eye Hospital and Institute Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Apollo Hospitals Enterprise
Bullish
7,651.950.731,10,023.3071.0912.560.2683.18
Fortis Healthcare
Bullish
908.050.1568,516.1980.047.640.1125.92
Max Healthcare Institute
Neutral
1,080.750.441,05,118.1593.4311.210.1429.50
Narayana Hrudayalaya
Neutral
1,830.000.0837,466.6647.6610.510.2459.03
Global Health
Neutral
1,169.20-0.3631,486.0061.739.450.0418.41
Lotus Eye Hospital and Institute Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-11Quarterly Results
2025-11-12Quarterly Results
2025-08-12Quarterly Results
2025-05-29Audited Results
2025-02-12Quarterly Results
About the company Lotus Eye Hospital and Institute
  • IndustryHealthcare Facilities
  • ISININE947I01017
  • BSE Code532998
  • NSE CodeLOTUSEYE
Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company is engaged in the field of ophthalmology (eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides various treatments, suchas ReLEx SMILE, Touchfree Laser, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates in various locations, such as Sitra, Coimbatore; RS Puram, Coimbatore; Salem; Tirupur; Mettupalayam; Kochi; Mulanthuruthy; Saravanampatty, and Karur.
  • Management Info
  • Kavetha SundaramoorthyChairman of the Board
  • Ramanujam ReghunathanChief Financial Officer
  • M Achuth MenonCompany Secretary, Compliance Officer
  • Sangeetha SundaramoorthyManaging Director, Executive Director
Lotus Eye Hospital and Institute Share Price FAQs

Lotus Eye Hospital and Institute is trading at 129.90 as on Wed Feb 18 2026 04:42:51. This is 4.97% upper as compared to its previous closing price of 123.75.

The market capitalization of Lotus Eye Hospital and Institute is 270.03 Cr as on Wed Feb 18 2026 04:42:51.

The 52 wk high for Lotus Eye Hospital and Institute is 147.60 whereas the 52 wk low is 55.31

Lotus Eye Hospital and Institute can be analyzed on the following key metrics -

  • TTM P/E: 343.01
  • Sector P/E: 29.67
  • Dividend Yield: 0.00%
  • D/E ratio: 0.08

Lotus Eye Hospital and Institute reported a net profit of 0.74 Cr in 2025.